The AAA Get Fit Trial: A Pilot Randomised Controlled Trial of Community Based Exercise in Patients With Abdominal Aortic Aneurysms

NCT ID: NCT02997618

Last Updated: 2018-10-17

Basic Information

• Recruitment Status: UNKNOWN
• Clinical Phase: NA
• Total Enrollment: 58 participants
• Study Classification: INTERVENTIONAL
• Study Start Date: 2018-11-30
• Study Completion Date: 2019-04-30

Brief Summary

Rupture of abdominal aortic aneurysms(AAA) causes 12,000 deaths/year in the UK.1 Elective repair to prevent this carries a perioperative mortality of 4.5% for open surgery and 1% for endovascular repair. This risk is associated with poor cardiorespiratory fitness which can be measured using Cardiopulmonary Exercise Testing(CPET) with the CPET variables, peak oxygen uptake(peakVO2)<15ml/kg/min and anaerobic threshold(AT)<10.2ml/kg/min identifying patients at increased risk of early death after AAA repair.3 These variables can therefore be used as surrogate markers for cardiovascular fitness and risk of mortality and morbidity in AAA surgery; optimising these markers should improve fitness and decrease this risk. The optimal duration and type of exercise training for improving peak VO2 and AT in AAA patients is not known. AAA patients are unique as they are motivated to reduce the risk of impending surgery but are afforded the time to improve their fitness as repair may not be needed for months or even years.

The investigators propose a pilot randomised controlled trial to explore the effectiveness of a 20-week community (either home or gym-based) exercise programme to achieve sustained improvements in peak VO2 and AT, as measured by CPET, in AAA patients. Changes in QoL, habitual activity levels and cardiovascular risk will also be assessed. The results will inform a definitive multicentre clinical trial on exercise to improve outcomes in elderly patients with cardiovascular disease and AAA.

Conditions

Aortic Aneurysm, Abdominal

Study Design

• Allocation Method: RANDOMIZED
• Intervention Model: PARALLEL
• Primary Study Purpose: PREVENTION
• Blinding Strategy: SINGLE

Study Groups

Control

1. Usual care (control)

Usual care given to patients on AAA surveillance. This includes six-monthly or annual ultrasound measurements of AAA, attendance to surveillance clinic and written (APPENDIX A) and verbal advice on managing cardiovascular risk. This advice will be based on current widely available NHS patient information15 and consists of the following information with regard to:

Smoking Exercise Weight Diet

Group Type: ACTIVE_COMPARATOR

Control

Intervention Type: OTHER

Usual care consisting of advice.

Community Based Exercise Programme

Community based-exercise (in addition to usual care) with the choice of either:

1. Home-based exercise training Participants choosing to exercise at home will follow the programmes intended for this setting, with each exercise designed to be possible without the need for specialist equipment.

2. Gym-based exercise training Participants will exercise at their nearest Life Leisure LTD gym, following one of the instructor designed programmes , using a combination of aerobic and resistance equipment, as well as simple floor exercises.

Duration and Frequency At least 50 minutes of exercise per day on three non-consecutive days of the week for 20 weeks.

Group Type: EXPERIMENTAL

Community based exercise programme

Intervention Type: BEHAVIORAL

20 week community (home or gym based) exercise programme

Interventions

Community based exercise programme

20 week community (home or gym based) exercise programme

Intervention Type: BEHAVIORAL

Control

Usual care consisting of advice.

Intervention Type: OTHER

Eligibility Criteria

Inclusion Criteria

1. Men with an AAA ≥ 3.0 and < 5.0 cm and women with a AAA ≥ 3.0 and < 4.5 cm

2. Aged 60 - 85 years inclusive

3. Willing and able to engage in gym- and/or home-based exercise training and undertake CPET

Exclusion Criteria

1. Unable or unwilling to undertake CPET or exercise training Patients unwilling will not be able to give informed consent and those who are unable would not be able to be randomised to the intervention study group nor undergo satisfactory testing to obtain our outcome measures.

2. High levels of habitual physical activity (those scoring "high" on the PASE questionnaire) These patients already have a high level of physical activity and therefore it may not be possible to improve their fitness any further which is the primary objective of the study.

3. Severe liver disease (INR > 2, serum albumin < 3.0g/dL, bilirubin > 50µmol/L)

4. Unstable angina, angina of < 2 month's duration, occurring more than twice daily, angina that is increasing in frequency or precipitated by less exertion, angina at rest

5. Uncontrolled atrial fibrillation (AF) or other arrhythmia: untreated paroxysmal AF

6. Moderate or severe aortic valve stenosis (peak systolic pressure gradient >40mmHg or with an aortic valve area < 1cm2)

7. Class II/III/IV heart failure and/or left ventricular ejection fraction < 25%

8. Pericarditis or myocarditis within last six months

9. Patients with > 2mm ST depression on exercise ECG will not be eligible to take part and will be referred to a cardiologist for further assessment.

10. Diagnosis or treatment for a malignancy over the previous 12 months

• Minimum Eligible Age: 60 Years
• Maximum Eligible Age: 85 Years
• Eligible Sex: ALL
• Accepts Healthy Volunteers: No

Sponsors

Manchester University NHS Foundation Trust

OTHER_GOV

Sponsor Role: collaborator

University of Manchester

OTHER

Sponsor Role: lead

Responsible Party

Charles McCollum

Professor

Responsibility Role: PRINCIPAL_INVESTIGATOR

Principal Investigators

Charles McCollum, MD, FRCS

Role: PRINCIPAL_INVESTIGATOR

University of Manchester

Central Contacts

Adam Haque, MBChB, MRCS

Role: CONTACT

adam.haque@manchester.ac.uk

01612915848

Other Identifiers

162347

Identifier Type: -

Identifier Source: org_study_id